EQRx, Inc.

EQRx, Inc. is a biopharmaceutical company that went public through a merger with CM Life Sciences III Acquisition Corp., which traded on Nasdaq under the ticker CMLT. The SPAC was sponsored by CM Life Sciences LLC and completed its initial public offering in 2021, targeting the healthcare and life sciences sector. On November 23, 2021, EQRx filed a Form 10-Q/A, an amended quarterly report, under accession number 0001213900-21-061645, reflecting updated financial disclosures as the de-SPAC transaction progressed toward closing. EQRx focused on developing and commercializing innovative medicines at significantly reduced prices. Visit SpacDesk and sign up for full data, filings history, and deal analytics on CMLT and hundreds of other SPAC transactions.